CAS 163046-73-9 występuje w naszej ofercie pod nazwami: Cimicifugoside H1, Cimicifugoside H-1/ 99.91% (existing batch purity), Cimicifugoside H–1, Cimicifugoside H1, (1S,2aR,3R,5aR,7aR,9S,11aR,12aS)-3-((R)-4-((R)-3,3-Dimethyloxiran-2-yl)-4-oxobutan-2-yl)-1-hydroxy-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,2,2a,3,5,5a,7,7a,8,9,10,11-dodecahydro-4H,12H-cyclopenta[a]cyclopropa[e]phenanthren-4-one. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 1mg, 10mg, 25mg, 50mg, 100mg, 2mg, 5 mg.
(1S,3R,6S,8R,12R,15R,16R,18S)-15-[(2R)-4-[(2R)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentacyclo[9.7.0.01,3.03,8.012,16]octadec-10-en-14-one (CAS 163046-73-9) to związek chemiczny o wzorze sumarycznym C35H52O9 i masie molowej 616.8 g/mol. Nazwa systematyczna IUPAC: (1S,3R,6S,8R,12R,15R,16R,18S)-15-[(2R)-4-[(2R)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentacyclo[9.7.0.01,3.03,8.012,16]octadec-10-en-14-one. InChIKey: PYBFXJMIKJNNAJ-GLWILYKISA-N.
| Wzór sumaryczny | C35H52O9 |
|---|---|
| Masa molowa | 616.8 g/mol |
| Nazwa IUPAC | (1S,3R,6S,8R,12R,15R,16R,18S)-15-[(2R)-4-[(2R)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-18-hydroxy-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxypentacyclo[9.7.0.01,3.03,8.012,16]octadec-10-en-14-one |
| InChIKey | PYBFXJMIKJNNAJ-GLWILYKISA-N |
| SMILES | C[C@H](CC(=O)[C@H]1C(O1)(C)C)[C@H]2C(=O)C[C@@]3([C@@]2(C[C@@H]([C@]45C3=CC[C@@H]6[C@]4(C5)CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)C)C |
Dane obliczone przez PubChem (NCBI)